Dexmedetomidine Completed Phase 1 Trials for Dexmedetomidine (DB00633)

IndicationStatusPhase
DBCOND0050052 (Dexmedetomidine)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03417999Pharmacokinetic Study of Intranasal Dexmedetomidine in Pediatric Patients With Congenital Heart DiseaseOther